JPMorgan Chase & Co. Lowers Evolent Health (NYSE:EVH) Price Target to $12.00
Evolent Health (NYSE:EVH – Free Report) had its target price decreased by JPMorgan Chase & Co. from $13.00 to $12.00 in a report issued on Monday morning,Benzinga reports. JPMorgan Chase & Co. currently has an overweight rating on the technology company’s stock. Several other brokerages have also recently weighed in on EVH. Stephens dropped their […]
Evolent Health (NYSE:EVH – Free Report) had its target price decreased by JPMorgan Chase & Co. from $13.00 to $12.00 in a report issued on Monday morning,Benzinga reports. JPMorgan Chase & Co. currently has an overweight rating on the technology company’s stock. Several other brokerages have also recently weighed in on EVH. Stephens dropped their […]
